Latest Implications of Next-Gen Sequencing in Diagnosis of Acute and Chronic Myeloid Leukemia
The spectacular progress which was present in the past few years in the field of genome sequencing, together with the appearance on the market of some high performance devices in this field, the reduction of the costs regarding the analysis of the samples and the standardization of some protocols, h...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2020
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/71721 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| _version_ | 1879164705168162816 |
|---|---|
| author | Boldura, Oana Maria Petrine, Cristina Mihu, Alin Balta, Cornel |
| author_browse | Balta, Cornel Boldura, Oana Maria Mihu, Alin Petrine, Cristina |
| author_facet | Boldura, Oana Maria Petrine, Cristina Mihu, Alin Balta, Cornel |
| author_sort | Boldura, Oana Maria |
| building | IntechOpen |
| collection | Acceso abierto |
| description | The spectacular progress which was present in the past few years in the field of genome sequencing, together with the appearance on the market of some high performance devices in this field, the reduction of the costs regarding the analysis of the samples and the standardization of some protocols, has led to the establishment and introduction of the new generation of sequencing techniques in clinical diagnostic labs. An important role is played by the implementation of this technique in the oncology clinics. In this context, we found it appropriate to discuss in this chapter about the role of next-gen sequencing in determining the genetic probabilities of occurrence of oncological pathologies in the healthy population, the screening of these diseases at the population level, the diagnosis and classification of this pathology, the establishment of the therapeutic conduct using the technique, as well as the progression of the disease. In this chapter, we intend to discuss in particular the involvement of this technology in hemato-oncological diseases. |
| doi_str_mv | 10.5772/intechopen.92068 |
| first_indexed | 2026-10-15T21:38:35Z |
| format | Book Chapter |
| fullrecord | <oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><identifier>intech-71721</identifier><datestamp>2020-04-08</datestamp>
<dc:title>Latest Implications of Next-Gen Sequencing in Diagnosis of Acute and Chronic Myeloid Leukemia</dc:title>
<dc:creator>Oana Maria Boldura</dc:creator>
<dc:creator>Cristina Petrine</dc:creator>
<dc:creator>Alin Mihu</dc:creator>
<dc:creator>Cornel Balta</dc:creator>
<dc:subject>Life Sciences</dc:subject>
<dc:description>The spectacular progress which was present in the past few years in the field of genome sequencing, together with the appearance on the market of some high performance devices in this field, the reduction of the costs regarding the analysis of the samples and the standardization of some protocols, has led to the establishment and introduction of the new generation of sequencing techniques in clinical diagnostic labs. An important role is played by the implementation of this technique in the oncology clinics. In this context, we found it appropriate to discuss in this chapter about the role of next-gen sequencing in determining the genetic probabilities of occurrence of oncological pathologies in the healthy population, the screening of these diseases at the population level, the diagnosis and classification of this pathology, the establishment of the therapeutic conduct using the technique, as well as the progression of the disease. In this chapter, we intend to discuss in particular the involvement of this technology in hemato-oncological diseases.</dc:description>
<dc:publisher>IntechOpen</dc:publisher>
<dc:date>2020-04-08</dc:date>
<dc:type>Chapter, Part Of Book</dc:type>
<dc:identifier>https://www.intechopen.com/chapters/71721</dc:identifier>
<dc:identifier>doi:10.5772/intechopen.92068</dc:identifier>
<dc:language>en</dc:language>
<dc:relation>ISBN:978-1-78984-856-4</dc:relation>
<dc:rights>https://creativecommons.org/licenses/by/3.0/</dc:rights>
<dc:source>https://www.intechopen.com/books/8912 ; Biochemical Analysis Tools - Methods for Bio-Molecules Studies</dc:source>
</oai_dc:dc> |
| id | intech-71721 |
| institution | IntechOpen |
| isbn | 978-1-78984-856-4 |
| language | English |
| last_indexed | 2026-10-15T21:38:35Z |
| publishDate | 2020 |
| publishDateRange | 2020 |
| publishDateSort | 2020 |
| publisher | IntechOpen |
| publisherStr | IntechOpen |
| record_format | oai_dc |
| spelling | intech-717212020-04-08 Latest Implications of Next-Gen Sequencing in Diagnosis of Acute and Chronic Myeloid Leukemia Oana Maria Boldura Cristina Petrine Alin Mihu Cornel Balta Life Sciences The spectacular progress which was present in the past few years in the field of genome sequencing, together with the appearance on the market of some high performance devices in this field, the reduction of the costs regarding the analysis of the samples and the standardization of some protocols, has led to the establishment and introduction of the new generation of sequencing techniques in clinical diagnostic labs. An important role is played by the implementation of this technique in the oncology clinics. In this context, we found it appropriate to discuss in this chapter about the role of next-gen sequencing in determining the genetic probabilities of occurrence of oncological pathologies in the healthy population, the screening of these diseases at the population level, the diagnosis and classification of this pathology, the establishment of the therapeutic conduct using the technique, as well as the progression of the disease. In this chapter, we intend to discuss in particular the involvement of this technology in hemato-oncological diseases. IntechOpen 2020-04-08 Chapter, Part Of Book https://www.intechopen.com/chapters/71721 doi:10.5772/intechopen.92068 en ISBN:978-1-78984-856-4 https://creativecommons.org/licenses/by/3.0/ https://www.intechopen.com/books/8912 ; Biochemical Analysis Tools - Methods for Bio-Molecules Studies |
| spellingShingle | Life Sciences Boldura, Oana Maria Petrine, Cristina Mihu, Alin Balta, Cornel Latest Implications of Next-Gen Sequencing in Diagnosis of Acute and Chronic Myeloid Leukemia |
| title | Latest Implications of Next-Gen Sequencing in Diagnosis of Acute and Chronic Myeloid Leukemia |
| title_full | Latest Implications of Next-Gen Sequencing in Diagnosis of Acute and Chronic Myeloid Leukemia |
| title_fullStr | Latest Implications of Next-Gen Sequencing in Diagnosis of Acute and Chronic Myeloid Leukemia |
| title_full_unstemmed | Latest Implications of Next-Gen Sequencing in Diagnosis of Acute and Chronic Myeloid Leukemia |
| title_short | Latest Implications of Next-Gen Sequencing in Diagnosis of Acute and Chronic Myeloid Leukemia |
| title_sort | latest implications of next gen sequencing in diagnosis of acute and chronic myeloid leukemia |
| topic | Life Sciences |
| url | https://www.intechopen.com/chapters/71721 |
| work_keys_str_mv | AT bolduraoanamaria latestimplicationsofnextgensequencingindiagnosisofacuteandchronicmyeloidleukemia AT petrinecristina latestimplicationsofnextgensequencingindiagnosisofacuteandchronicmyeloidleukemia AT mihualin latestimplicationsofnextgensequencingindiagnosisofacuteandchronicmyeloidleukemia AT baltacornel latestimplicationsofnextgensequencingindiagnosisofacuteandchronicmyeloidleukemia |